Navigation Links
Sunpeaks Ventures Inks Sponsorship and Marketing Agreement with Major Sports Team, Clotamin To Be Sold at Walgreens Locations Throughout Oregon and Southern Washington
Date:4/6/2012

SILVER SPRING, Md., April 6, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to announce that HDS has entered into a sponsorship agreement ("Agreement") with a major pro sports team ("Team") for the marketing of Clotamin, including advertising, media, and promotional elements. The Agreement is part of new marketing initiatives to launch Clotamin in 79 Walgreens stores in Oregon and southern Washington.

Under terms of the Agreement, HDS, in conjunction with Walgreens, will have the right to make use of the Team name and logo in connection with all advertising retail displays to be placed at Walgreens locations in the Portland, Oregon, metropolitan area. HDS and Walgreens will also receive digital advertising space in the Rose Garden Arena on the lower ring and corners of the scoreboard and on all televisions menu boards at the arena during all Team home games. Clotamin advertising will also be displayed on the Team websites, subject to approval.

"We continue to grow awareness and acceptance of Clotamin nationwide through quality advertising, strong endorsements, and strategic sponsorships," stated Mackie A. Barch, CEO of Sunpeaks Ventures. "Launching in Oregon with pharmacy powerhouse Walgreens and a highly-recognizable pro sports team focused marketing campaign will allow us to quickly introduce the benefits of Clotamin to their many loyal customers and fans."

In addition, the Team has also agreed to provide promotional elements to support a no-purchase necessary, enter-to-win sweepstakes sponsored by HDS, Walgreens, and the Team, in connection with the advertising retail displays to be placed at Walgreens locations. Promotional elements may include, but are not limited to, tickets to Team home games, team clothing or merchandise, gift bags containing Team souvenirs, post-game events, tickets to non-Team events at the Rose Garden Arena, and gift cards.

Established in 1901, Walgreens is a national leader at developing and implementing innovative pharmacy practices from online sales to advanced Medical Therapy Management (MTM). Walgreens has been included for 19 consecutive years on Fortune Magazine's "World's Most Admired Companies" list. Walgreens has over 8350 stores throughout the United States.

About Sunpeaks Ventures, Inc.

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.

For additional information, please visit www.sunpeaksventures.com.

Contact: Financial Insights 888-248-8491 or info@sunpeaksventures.com

Safe Harbor Statement

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.


'/>"/>
SOURCE Sunpeaks Ventures, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunpeaks Ventures Announces Agreement with Asian American Convenience Store Association Partners to Sell Clotamin in 1,200 Stores
2. Sunpeaks Ventures Announces Agreement with Albeck Financial Services
3. Sunpeaks Ventures Announces Clotamin to Be Sold at Winn-Dixie Locations in South Florida
4. Sunpeaks Ventures Announces Clotamin to be Sold at Bravo Supermarkets in South Florida
5. Sunpeaks Ventures to Participate in ECRM Conference and Expo
6. Sunpeaks Ventures Announces Clotamin to be Sold at Navarro Discount Pharmacies
7. Sunpeaks Ventures Announces Clotamin available on Walgreens.com
8. Sunpeaks Ventures Enters $45 Billion Specialty Drug Distribution Sector
9. Sunpeaks Ventures Completes Acquisition of Healthcare Distribution Specialists LLC
10. GMH Ventures Acquires Majority Ownership in Dynamic Healthcare Services, Leading Provider of Medical Equipment and Respiratory Therapy Products and Services
11. Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 2017 Shire plc (LSE: SHP, ... Food and Drug Administration (FDA) has acknowledged receipt of ... (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine salts ... treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected ... 2017, the designated Prescription Drug User Fee Act (PDUFA) ...
(Date:1/19/2017)... 19, 2017 While various ... about reducing the FDA,s regulatory strictness as a ... medical drug industry, many of the leading biotech ... trials and development of advanced drug treatments and ... recent developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
(Date:1/19/2017)... The Global Therapy Partnering Terms and Agreements ... deals and agreements entered into by the world,s leading ... Top deals by value - Deals listed by company ... The report provides understanding and access to the partnering ... healthcare companies. The report provides an analysis of ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... 2017 , ... Bio-Optronics Inc. is proud to announce the ... to seamlessly integrate and streamline the way researchers prepare and conduct patient visits. ... and improving efficiency significantly for users – a first in the CTMS industry. ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Students interested in ... Donation Awareness Scholarship competition., The winner will earn a $1,000 scholarship and have his ... begins Feb. 1, and the deadline is May 31, with the winner announced on ...
(Date:1/19/2017)... ... January 19, 2017 , ... Workrite Ergonomics announced this week ... Tranquility privacy panel system was designed to deliver the ideal blend of acoustic ... and provide the visual privacy required to maintain concentration levels and increase productivity. ...
(Date:1/19/2017)... ... ... Allegheny Health Network (AHN) officials today announced a bold new step to ... services in the greater Pittsburgh region. Starting January 23, patients who call AHN by ... same afternoon. , AHN is the first healthcare provider in the ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... protection and financial planning services to communities throughout eastern Georgia, is embarking on ... heart disease. , Heart disease kills more Americans every year than anything else, ...
Breaking Medicine News(10 mins):